Matriks Bilgi Dagitim Hizmetleri AS (MTRKS) - Total Liabilities
Based on the latest financial reports, Matriks Bilgi Dagitim Hizmetleri AS (MTRKS) has total liabilities worth TL264.43 Million TRY (≈ $5.92 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MTRKS cash flow metrics to assess how effectively this company generates cash.
Matriks Bilgi Dagitim Hizmetleri AS - Total Liabilities Trend (2018–2024)
This chart illustrates how Matriks Bilgi Dagitim Hizmetleri AS's total liabilities have evolved over time, based on quarterly financial data. Check MTRKS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Matriks Bilgi Dagitim Hizmetleri AS Competitors by Total Liabilities
The table below lists competitors of Matriks Bilgi Dagitim Hizmetleri AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reitmans (Canada) Limited
V:RET-A
|
Canada | CA$251.59 Million |
|
Universal Textile Co Ltd
TW:1445
|
Taiwan | NT$2.38 Billion |
|
Shah Metacorp Limited
NSE:SHAH
|
India | Rs1.65 Billion |
|
Do Day Dream Public Company Limited
BK:DDD
|
Thailand | ฿309.00 Million |
|
Supra Boga Lestari Tbk
JK:RANC
|
Indonesia | Rp911.49 Billion |
|
Yooshin Engineering Corporation
KQ:054930
|
Korea | ₩184.07 Billion |
|
Annovis Bio Inc
NYSE:ANVS
|
USA | $4.03 Million |
|
Metagenomi, Inc. Common Stock
NASDAQ:MGX
|
USA | $69.49 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Matriks Bilgi Dagitim Hizmetleri AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Matriks Bilgi Dagitim Hizmetleri AS worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Matriks Bilgi Dagitim Hizmetleri AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Matriks Bilgi Dagitim Hizmetleri AS (2018–2024)
The table below shows the annual total liabilities of Matriks Bilgi Dagitim Hizmetleri AS from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | TL196.74 Million ≈ $4.41 Million |
+78.39% |
| 2023-12-31 | TL110.29 Million ≈ $2.47 Million |
+102.04% |
| 2022-12-31 | TL54.59 Million ≈ $1.22 Million |
+73.38% |
| 2021-12-31 | TL31.48 Million ≈ $705.15K |
+19.19% |
| 2020-12-31 | TL26.41 Million ≈ $591.62K |
+34.09% |
| 2019-12-31 | TL19.70 Million ≈ $441.20K |
+34.16% |
| 2018-12-31 | TL14.68 Million ≈ $328.86K |
-- |
About Matriks Bilgi Dagitim Hizmetleri AS
Matriks Finansal Teknolojiler A.S., a fintech company, provides real-time and analytical data, news, and commentary on financial markets. Its products include MatriksIQ data terminal, matrix mobile IQ, matrix web trader, Matriks prime data terminal, and algorithmic trading products; and data and content provider services, product development, algorithmic trading platforms, content management syst… Read more